Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

H G Jorgensen, E K Allan, J C Mountford, L Richmond, M A Elliott, T L Holyoake

Research output: Contribution to journalConference Contribution

Abstract

Meeting abstract 1997 looks at enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro
Original languageEnglish
Article number1997
Pages (from-to)551A-551A
Number of pages1
JournalBlood
Volume104
Issue number11
Publication statusPublished - 16 Nov 2004
Event46th Annual Meeting of the American-Society-of-Hematology - San Diego, United States
Duration: 4 Dec 20047 Dec 2004

Keywords

  • enhanced
  • primary cml stem cell elimination
  • bryostatin priming
  • imatinib mesylate
  • in vitro

Fingerprint Dive into the research topics of 'Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro'. Together they form a unique fingerprint.

  • Cite this

    Jorgensen, H. G., Allan, E. K., Mountford, J. C., Richmond, L., Elliott, M. A., & Holyoake, T. L. (2004). Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro. Blood, 104(11), 551A-551A. [1997].